- Home
- IBIO vs SNES Comparison
IBIO vs SNES Comparison
Compare IBIO & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBIO | SNES |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4M | 14.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | IBIO | SNES |
|---|---|---|
| Price | $1.96 | $2.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $4.50 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 13.0M | 52.0K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $500,000.00 | ★ $2,301,000.00 |
| Revenue This Year | N/A | $41.52 |
| Revenue Next Year | $11.11 | $77.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 185.71 | 39.37 |
| 52 Week Low | $0.56 | $1.30 |
| 52 Week High | $6.89 | $6.24 |
Technical Indicators
Market Signals| Indicator | IBIO | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 35.61 |
| Support Level | $0.98 | $2.70 |
| Resistance Level | $3.82 | $2.94 |
| Average True Range (ATR) | 0.38 | 0.20 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 33.63 | 0.00 |
Price Performance
Historical ComparisonAbout IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.